Detalles de la búsqueda
1.
First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes.
BMC Med
; 21(1): 190, 2023 05 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37226224
2.
Interferon α kinoid induces neutralizing anti-interferon α antibodies that decrease the expression of interferon-induced and B cell activation associated transcripts: analysis of extended follow-up data from the interferon α kinoid phase I/II study.
Rheumatology (Oxford)
; 55(10): 1901-5, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27354683
3.
Down-regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon α-kinoid.
Arthritis Rheum
; 65(2): 447-56, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23203821
4.
A phase 1/2 clinical trial evaluating safety and immunogenicity of a varicella zoster glycoprotein e subunit vaccine candidate in young and older adults.
J Infect Dis
; 206(8): 1280-90, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22872734
5.
Artificial Cell Membrane Polymersome-Based Intranasal Beta Spike Formulation as a Second Generation Covid-19 Vaccine.
ACS Nano
; 16(10): 16757-16775, 2022 10 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-36223228
6.
Active immunisation of human interferon α transgenic mice with a human interferon α Kinoid induces antibodies that neutralise interferon α in sera from patients with systemic lupus erythematosus.
Ann Rheum Dis
; 70(6): 1138-43, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21389044
7.
Glycoprotein-D-adjuvant vaccine to prevent genital herpes.
N Engl J Med
; 347(21): 1652-61, 2002 Nov 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-12444179
8.
Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination.
Vaccine
; 33(8): 1084-91, 2015 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-25444781
9.
Adjuvant system AS02V enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: randomised, controlled trials.
Vaccine
; 33(4): 577-84, 2015 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24176494
10.
Therapeutic vaccination against chronic viral infections.
Lancet Infect Dis
; 2(6): 353-67, 2002 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-12144898
11.
Randomized controlled study of the safety and immunogenicity of pneumococcal vaccine formulations containing PhtD and detoxified pneumolysin with alum or adjuvant system AS02V in elderly adults.
Clin Vaccine Immunol
; 21(5): 651-60, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24599529
12.
Therapeutic vaccination with TNF-Kinoid in TNF antagonist-resistant rheumatoid arthritis: a phase II randomized, controlled clinical trial.
PLoS One
; 9(12): e113465, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25517733
13.
Immunogenicity and safety of different formulations of an adjuvanted glycoprotein D genital herpes vaccine in healthy adults: a double-blind randomized trial.
Hum Vaccin Immunother
; 9(6): 1254-62, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23434737
14.
The candidate tuberculosis vaccine Mtb72F/AS02 in PPD positive adults: a randomized controlled phase I/II study.
Tuberculosis (Edinb)
; 93(2): 179-88, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23219236
15.
Induction of strong HIV-1-specific CD4+ T-cell responses using an HIV-1 gp120/NefTat vaccine adjuvanted with AS02A in antiretroviral-treated HIV-1-infected individuals.
J Acquir Immune Defic Syndr
; 59(1): 1-9, 2012 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21963936
16.
Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems.
Vaccine
; 28(43): 7016-24, 2010 Oct 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-20728522
17.
Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
Vaccine
; 26(10): 1375-86, 2008 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-18272264
18.
Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: a randomized, controlled study of co-administration of HBsAg/AS02 candidate vaccine and lamivudine.
Vaccine
; 25(51): 8585-97, 2007 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-18031872
19.
Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers.
Vaccine
; 25(3): 510-8, 2007 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-17049679
20.
Potent enhancement of cellular and humoral immune responses against recombinant hepatitis B antigens using AS02A adjuvant in healthy adults.
Vaccine
; 23(20): 2591-601, 2005 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-15780441